Xeris Biopharma Holdings Inc
NASDAQ:XERS

Watchlist Manager
Xeris Biopharma Holdings Inc Logo
Xeris Biopharma Holdings Inc
NASDAQ:XERS
Watchlist
Price: 3.09 USD 1.64% Market Closed
Market Cap: 460.4m USD
Have any thoughts about
Xeris Biopharma Holdings Inc?
Write Note

EV/EBIT
Enterprise Value to EBIT

-13.4
Current
-6.5
Median
16.6
Industry
Lower than median
Lower than industry value

Enterprise Value to EBIT (EV/EBIT) ratio is a valuation multiple that compares the value of a company, debt included, to the company’s earnings before interest and taxes (EBIT). Considered one of the most frequently used multiples for comparisons among companies, the EV/EBIT multiple relies on operating income as the core driver of valuation.

EV/EBIT
-13.4
=
Enterprise Value
607.2m USD
/
EBIT
-45.2m USD
All Countries
Close

EV/EBIT Forward Multiples

Forward EV/EBIT multiple is a version of the EV/EBIT ratio that uses forecasted EBIT for the EV/EBIT calculation. 1-Year, 2-Years, and 3-Years forwards use EBIT forecasts for 1, 2, and 3 years ahead, respectively.

1-Year Forward
EV/EBIT
-18.9
2-Years Forward
EV/EBIT
-58.2
3-Years Forward
EV/EBIT
16.4

See Also

Discover More